Quick Answer
MUSTANG BIO, INC. reported Net Income Loss of -$1.92 million for the year ending 2025.
- MUSTANG BIO, INC. showed an increase of +87.8% in Net Income Loss from 2024 to 2025.
- This data is from MUSTANG BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), MUSTANG BIO, INC.'s Net Income Loss has grown by 15.0%.
- Historical annual values: Fiscal year 2025: -$1.92 million | Fiscal year 2024: -$15.75 million | Fiscal year 2023: -$51.60 million | Fiscal year 2022: -$77.53 million | Fiscal year 2021: -$66.37 million | Fiscal year 2020: -$60.02 million | Fiscal year 2019: -$46.39 million | Fiscal year 2018: -$30.66 million | Fiscal year 2017: -$31.29 million | Fiscal year 2016: -$12.65 million | Fiscal year 2015: -$2.26 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: